FUNCTIONAL EVIDENCE FOR AN APICAL ANP RECEPTOR IN LLC-PK1 KIDNEY EPITHELIAL-CELLS

被引:0
|
作者
HASHIMOTO, Y
OZAKI, J
YASUHARA, M
HORI, R
SUGA, S
ITOH, H
NAKAO, K
INUI, K
机构
[1] KYOTO UNIV HOSP,FAC MED,DEPT PHARM,SAKYO KU,KYOTO 606,JAPAN
[2] KINKI UNIV,INST PHARMACEUT RES & TECHNOL,OSAKA,OSAKA 577,JAPAN
[3] KYOTO UNIV,FAC MED,DEPT MED,DIV 2,SAKYO KU,KYOTO 606,JAPAN
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1994年 / 268卷 / 03期
关键词
ANP (ATRIAL NATRIURETIC PEPTIDE); NATRIURETIC PEPTIDE; C-TYPE; GUANYLATE CYCLASE; LLC-PK1; CELL;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The localization of natriuretic peptide receptors was studied in LLC-PK1 cell monolayers grown on a micro-porous membrane filter. The addition of alpha-human atrial natriuretic peptide (alpha-hANP) to the apical side of the cells produced a concentration-dependent increase in cyclic GMP (cGMP) formation, the extent of which was similar to that produced by the addition to the basolateral side. More cGMP was formed with alpha-hANP (1 and 100 nM) than with the C-type natriuretic peptide (100 nM). These findings indicate that the biologically active receptors with high efficacy for alpha-hANP are expressed in both the apical and basolateral membranes in LLC-PK1 cells.
引用
收藏
页码:443 / 445
页数:3
相关论文
共 50 条
  • [1] Uptake of doxorubicin by cultured kidney epithelial cells LLC-PK1
    Sasaya, M
    Wada, I
    Shida, M
    Sato, M
    Hatakeyama, Y
    Saitoh, H
    Takada, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (05) : 527 - 529
  • [2] The transport of ciprofloxacin in cultured kidney epithelial cells LLC-PK1
    Sasaya, M
    Oda, M
    Endo, T
    Saitoh, H
    Takada, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (08) : 887 - 891
  • [3] The transport of enoxacin in cultured kidney epithelial cells LLC-PK1
    Sasaya, M
    Shida, M
    Hirano, T
    Oda, M
    Endo, T
    Sakata, M
    Miyazaki, S
    Takada, M
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1996, 116 (06): : 497 - 503
  • [4] TRANSPORT OF PROCAINAMIDE IN A KIDNEY EPITHELIAL-CELL LINE LLC-PK1
    TAKANO, M
    KATO, M
    TAKAYAMA, A
    YASUHARA, M
    INUI, K
    HORI, R
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1108 (02) : 133 - 139
  • [5] Kinetic analysis of tetraethylammonium transport in the kidney epithelial cell line, LLC-PK1
    Tomita, Y
    Otsuki, Y
    Hashimoto, Y
    Inui, K
    PHARMACEUTICAL RESEARCH, 1997, 14 (09) : 1236 - 1240
  • [6] Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells
    Nakamura, T
    Kokuryo, T
    Okuda, M
    Hashimoto, Y
    Inui, KI
    PHARMACEUTICAL RESEARCH, 1999, 16 (07) : 1132 - 1135
  • [7] Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells:: role of basolateral membrane transport
    Okuda, M
    Tsuda, K
    Masaki, K
    Hashimoto, Y
    Inui, K
    TOXICOLOGY LETTERS, 1999, 106 (2-3) : 229 - 235
  • [8] Uptake of human urinary trypsin inhibitor by the kidney epithelial cell line, LLC-PK1
    Yamasaki, F
    Shinkawa, T
    Watanabe, M
    Mizota, M
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1996, 433 (1-2): : 9 - 15
  • [9] DOPAMINE SYNTHESIS AND RELEASE IN LLC-PK1 CELLS
    DAWSON, R
    PHILLIPS, MI
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (06): : 423 - 426
  • [10] Characterization of LLC-PK1 kidney epithelial cells as an in vitro model for studying renal tubular reabsorption of protein drugs
    Takakura, Y
    Morita, T
    Fujikawa, M
    Hayashi, M
    Sezaki, H
    Hashida, M
    Borchardt, RT
    PHARMACEUTICAL RESEARCH, 1995, 12 (12) : 1968 - 1972